The role of β-adrenergic sensitivity in the pathogenesis of hypoglycaemia unawareness

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 5, 2002, Pages 357-361

  Fritsche, Andreas ^a   Tschritter, O ^a   Haring H ^a   Gerich, J ^b   Stumvoll, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Avoidance of hypoglycaemia; Epinephrine; Hypoglycaemic clamp; Isoproterenol test

Indexed keywords

ADRENALIN; CATECHOLAMINE;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ARTICLE; AWARENESS; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHYSICAL SENSITIVITY; PRIORITY JOURNAL;

AUTONOMIC NERVOUS SYSTEM; AWARENESS; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; HUMANS; HYPOGLYCEMIA; RECEPTORS, ADRENERGIC, BETA;

EID: 0036826304     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gerich J.E., Mokan M., Veneman T., Korytkowski M., Mitrakou A.: Hypoglycaemia unawareness. Endocr. Rev. 12: 356-371, 1991.
2. Mokan M., Mitrakou A., Veneman T., Ryan C., Korytkowski M., Cryer P., Gerich J.: Hypoglycaemia unawareness in IDDM. Diabetes Care 17: 1397-1403, 1994.
3. Clarke W.L., Gonder-Frederick L., Richards F.E., Cryer P.E.: Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Diabetes 40: 680-685, 1991.
4. Polonsky K., Bergenstal R., Pons G., Schneider M., Jaspan J., Rubenstein A.: Relation of counterregulatory responses to hyoglycemia in type 1 diabetes. N. Engl. J. Med. 307: 1106-1112, 1982.
5. Grimaldi A., Bosquet F., Davidoff P., Digy J., Landault C., Therver F., Zoghbr F., Legrand J.: Unawareness of hypoglycaemia by insulin-dependent diabetics. Horm. Metab. Res. 22: 90-95, 1990.
6. Berlin I., Grimaldi A., Payan C., Sachon C., Bosquet F., Thervet F., Puech A.: Hypoglycaemia symptoms and decreased β-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care 10: 742-747, 1987.
7. Cleaveland C.R., Rango R.E., Clarke B.F.: A standardized isoproterenol sensitivity test. Arch. Intern. Med. 130: 47-52, 1972.
8. Trovik T.S., Jaeger R., Jorde R., Sager G.: Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness. Br. J. Clin. Pharmacol. 38: 427-432, 1994.
9. Korytkowski M., Mokan M., Veneman T.F., Mitrakou A., Cryer P.E., Gerich J.E. Reduced β-adrenergic sensitivity in patients with type 1 diabetes and hypoglycaemia unawareness. Diabetes Care 21: 1939-1943, 1998.
10. Fritsche A., Stumvoll M., Grüb M., Sieslack S., Renn W., Schmülling R.-M., Häring H.U., Gerich J.E. Effect of hypoglycaemia on β-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 21: 1505-1510, 1998.
11. Fritsche A., Stumvoll M., Stefan N., Häring H.U., Gerich J.E.: Avoidance of hypoglycaemia restores hypoglycaemia awareness by increasing β-adrenergic sinsitivity in type 1 diabetes. Ann. Intern. Med. 134: 729-736, 2001.
12. Berlin I., Grimaldi A., Bosquet F., Puech A.: Decreased β-adrenergic sensitivity in insulin-dependent diabetic subjects. J. Clin. Endocrinol. Metab. 63: 262-265, 1986.
13. Vestal R.E., Wood A.J., Shand D.G.: Reduced beta-adrenoceptor sensitivity in the elderly. Clin. Pharm. Ther. 26: 181-186, 1979.
14. Widom B., Simonson D.C.: Intermittend hypoglycaemia impairs glucose counterregulation. Diabetes 41: 1597-1602, 1992.
15. Heller S.R., Cryer P.E.: Reduced neuroendocrine, symptomatic responses to subsequent hypoglycaemia after one episode of hypoglycaemia in nondiabetic humans. Diabetes 40: 223-226, 1991.
16. Dagogo Jack S., Craft S., Cryer P.: Hypoglycaemia-associated autonomic failure in insulin dependent diabetes mellitus. J. Clin. Invest. 91: 819-828, 1993.
17. Lingenfelser T., Renn W., Sommerwerck U., Buettner U., Zaiser-Kaschel H., Kaschel R., Eggstein M., Jakober B.: Compromised hormonal counterregulation, symptom wareness, and neurophysiologic function after recurrent short-term episodes of insulin-induced hypoglycaemia in IDDM patients. Diabetes 42: 610-618, 1993.
18. Bolinder J., Sjöberg S., Arner P.: Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM. Diabetologia 39: 845-853, 1996.
19. Mitrakou A., Fanelli C., Veneman T., Perriello G., Calderone S., Platanisiotis D., Rambotti A., Raptis S., Brunetti P., Cryer P., Gerich J., Bolli G.: Reversibility of unawareness of hypoglycaemia in patients with insulinomas. N. Engl. J. Med. 329: 834-839, 1993.
20. Kendall D.M., Rooney D.P., Smets Y.F., Salazar Bolding L., Robertson R.P.: Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycaemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46: 249-257, 1997.
21. Fanelli C.G., Epifano L., Rambotti A.M., Pampanelli S., Di Vincenzo A., Modarelli F., Lepore M., Annibale B., Ciofetta M., Bottini P., Porcellati F., Scionti L., Santeusanio F., Brunetti P., Bolli G.B.: Meticulous prevention of hypoglycaemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycaemia in intensively treated patients with short-term IDDM. Diabetes 42: 1683-1689, 1993.
22. Fanelli C., Pampanelli S., Epifano L., Rambotti A.M., Di Vincenzo A., Modarelli F., Ciofetta M., Lepore M., Annibale B., Torlone E., Perriello G., De Feo P., Santeusanio F., Brunetti P., Bolli G.B.: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37: 1265-1276, 1994.
23. Cranston I., Lomas J., Maran A., Macdonald I., Amiel S.A.: Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344: 283-287, 1994.
24. Dagogo Jack S., Rattarasarn C., Cryer P.E.: Reversal of hypoglycaemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43: 1426-1434, 1994.
25. Kanc K., Janssen M.M., Keulen E.T., Jacobs M.A., Popp Snijders C., Snoek F.J., Heine R.J.: Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Diabetologia 41: 322-329, 1998.
26. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., Neifing J.L., Ward W.K., Beard J.C., Palmer J.P.: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672, 1993.
27. Weyer C., Bogardus C., Mott D.M., Pratley R.E.: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104: 787-794, 1999.